RNS Number : 3944P
Mediclinic International PLC
17 February 2016
 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

 

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:

Mediclinic International Plc (previously Al Noor Hospitals Group Plc)

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

X

Other (please specify):

 

 

3. Full name of person(s) subject to the
notification obligation:

Remgro Limited

4. Full name of shareholder(s)
 (if different from 3.):

Remgro Health Limited

Remgro Jersey GBP Limited

Remgro Healthcare Holdings Proprietary Limited

5. Date of the transaction and date on
which the threshold is crossed or
reached:

17/02/2016

6. Date on which issuer notified:

17/02/2016

7. Threshold(s) that is/are crossed or
reached:

Prior to transaction: 41%

Subsequent to transaction: 45%

     

  

 

8. Notified details:

A: Voting rights attached to shares

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary shares of 10p nominal value.

ISIN: GB00B8HX8Z88

328,497,888

328,497,888 (41%)

 

 

328,497,888

 

45%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date

Exercise/
Conversion Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date

Exercise/
Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

328,497,888

45%

                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

 

Remgro Limited (ultimate parent): Indirect holding of 45%.


Remgro Healthcare Holdings Proprietary Limited (wholly owned subsidiary of Remgro Limited): Direct holding of 35% (held on the SA branch register); indirect holding of 10%.

 

Millennia Jersey Ltd (wholly owned subsidiary of Remgro Healthcare Holdings Proprietary Limited): indirect holding of 10%.  
 

Remgro Health Limited (wholly owned subsidiary of Millennia Jersey Ltd: Direct holding of 5%.
 

Remgro Jersey GBP Limited (wholly owned subsidiary of Millennia Jersey Ltd: Direct holding of 5%.

 

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease
to hold:

 

12. Date on which proxy holder will cease to hold
voting rights:

 

 


13. Additional information:


 

14. Contact name:

Mariza Lubbe, Company Secretary

15. Contact telephone number:

+27 21 888 3000

   

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUBOWRNVAUAAR